Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • Telephone

      • +972-77-2005042 from 8 AM - 11 PM IL

      • Contact
      • Contact

        +972-77-2005042
        from 8 AM - 11 PM IL

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Request More Information
      • Journalists
      • GDPR

      InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

      InMode Logo (PRNewsfoto/InMode)

      News provided by

      InMode LTD

      31 Jul, 2024, 15:03 IDT

      Share this article

      Share this article


      IRVINE, Calif., July 31, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce the introduction of IgniteRF, a ground-breaking minimally invasive workstation inclusive of nine technologies which offer soft tissue contraction across multiple tissue depths.

      Continue Reading
      InMode LTD
      InMode LTD
      InMode LTD
      InMode LTD

      The IgniteRF platform, alongside the BodyTite, FaceTite, Morpheus8, and now QuantumRF family of products offers a comprehensive suite of radiofrequency solutions for various aesthetic and surgical needs. QuantumRF is a new, advanced minimally invasive technology which deploys fractionated radiofrequency to maximal depths.  The two lightweight and versatile cannulas, QuantumRF 10 for small, more delicate treatment zones and QuantumRF 25 for larger treatment zones enable physicians to deliver unprecedented results without invasive surgery.

      Radiofrequency (RF) technology has emerged as the gold standard in skin contraction within the aesthetics industry, due to its effectiveness, safety, and minimally or non-invasive nature. RF treatments heat the deeper layers of the skin, stimulating collagen production and promoting tissue remodeling. This process results in contracted, firmer skin and a more youthful appearance. One of the primary reasons RF is favored in aesthetics is its ability to deliver consistent and noticeable results with minimal discomfort and downtime. Unlike more surgical procedures, RF treatments do not require incisions or extensive surgery and recovery periods.

      "IgniteRF marks a significant milestone for InMode, with continued innovation to make our best in-class technology faster, smarter, and even more exceptional results," says Dr. Michael Kreindel, CTO and Co-founder of InMode. 

      Dr. Alfredo Hoyos, a board-certified plastic surgeon from Bogota, Colombia, worldwide renowned for his pioneering contributions to the body contouring field, has successfully completed over 100 QuantumRF procedures. He is the visionary creator of the High Definition Liposculpture technique, alongside Eve High Def (Full High-Def abdominoplasty), and Fit Mommy High Def (High Def mini-abdominoplasty). Dr. Hoyos commented, "QuantumRF is a ground-breaking advancement in skin retraction technology. Its internal bipolar system and fractional delivery eliminate the need for temperature build-up, making procedures remarkably fast and up to seven times more efficient than other devices. With QuantumRF, we have the best product available today, combining safety, efficiency, and unparalleled results."

      About InMode
      InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

      Press Contact:
      Behrman Cesa Communications
      [email protected]

      Investor Contact:
      MS-IR LLC
      Miri Segal – Scharia
      [email protected]
      Tel: 917-607-8654

      Photo - https://mma.prnewswire.com/media/2472167/AH_QuantumRF_Abs_Female.jpg
      Photo - https://mma.prnewswire.com/media/2472168/AH_QuantumRF_Abs_Male.jpg
      Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

      SOURCE InMode LTD

      Modal title

      Also from this source

      InMode Confirms Receipt of Unsolicited Proposal

      InMode Confirms Receipt of Unsolicited Proposal

      InMode Ltd. (Nasdaq: INMD) (the "Company") today announced that, on June 17, 2026, its Board of Directors (the "Board") received an unsolicited...

      InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

      InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

      InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced the appointment ...

      More Releases From This Source

      Contact PR Newswire

      • +972-77-2005042
        from 8 AM - 11 PM IL

      Global Sites

      • APAC
      • APAC - Traditional Chinese
      • Asia
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany

       

      • India
      • Indonesia
      • Israel
      • Italy
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland

       

      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Global Sites
      • Asia
      • Brazil
      • Canada
      • Csezh
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Israel
      • Italie
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      +972-77-2005042
      from 8 AM - 11 PM IL
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.